Treatment-Refractory Sternocostoclavicular Hyperostosis

Clin Med Res. 2017 Jun;15(1-2):37-40. doi: 10.3121/cmr.2017.1352.

Abstract

Sternocostoclavicular hyperostosis (SCCH) is an infrequent chronic inflammatory disorder of the axial skeleton of unknown origin. SCCH goes often unrecognized due to a low level of awareness for the disorder. It typically presents with relapsing and remitting pain in the shoulder, neck, and anterior chest wall area with occasional swelling and tenderness of the sternoclavicular area. The diagnosis is confirmed radiologically by sclerosis and hyperostosis of the sternoclavicular joints. There have been several reports in which intravenous bisphosphonates and tumor necrosis factor-inhibitors have shown reasonable efficacy in the treatment of this disorder. We report a patient with a long history of SCCH in whom pamidronate 60 mg intravenously every 3 months for 3 years failed to reduce symptom severity and improve radiologic findings.

Keywords: Bisphosphonates; Pamidronate; Sternocostoclavicular hyperostosis; Tumor necrosis factor-inhibitors.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Diphosphonates / administration & dosage*
  • Female
  • Humans
  • Hyperostosis, Sternocostoclavicular / diagnostic imaging*
  • Hyperostosis, Sternocostoclavicular / drug therapy*
  • Pamidronate
  • Treatment Failure

Substances

  • Diphosphonates
  • Pamidronate